Microsaic Systems Share Discussion Threads

[bones] 23/9/2019 11:36

Agreed K1ng.

Thanks, Dr Biotech, for the analysis.

[k1ngkonggb] 23/9/2019 11:35

Have to agree with Dr Biotech on the point of striking a deal with a major. This has to be an absolute must now and they should be prioritising this, as those sales won't do justice.

[dr biotech] 23/9/2019 11:26

Said here some time ago that I thought they'd never get enough sales to justify their £5m valuation. I work a lot in this field (particularly HPLC) and they are never going to make it big as its a niche product. To quote a £200bn market is ridiculous. Its like the owner of a chip shop saying they are addressing the £1trn food market.

They have about 20months cash left at current spend. To cover this with their current margins they would need about 10x current sales. Not going to happen - they need sales to be doubling and trebling not 30%.

The other thing to do is to click on their distributor websites to see how much prominence the MS's are given. Thats an indication of how hard the distributor will try and sell it.

£300k in sales is about 20 instruments. Lets say 1 a week and they struggle to make those.



The UK has a large & important presence in scientific instruments and we need companies like this to succeed and I hope they do. But I am not going to bet my own money on it.

Perhaps they will strike a deal with a major player (big names to look for are Agilent/Waters/Thermo/Shimadzu). The smaller companies such as ecom/data apex/Knauer have a decent presence in small labs and universities, but virtually none in big pharma.

Good luck to all here.

[2prsimo] 23/9/2019 10:05

Disappointing results - delays in delivery always a pain too

[k1ngkonggb] 23/9/2019 10:01

Back to the penny mark......must do better

[dave4545] 23/9/2019 09:37

Thought it might struggle but I did not see sales at 1.2p and at 1.125p on NEX.

This market is brutal, everybody is sitting on their hands and reluctant to buy.

[barnes4] 23/9/2019 09:34

The old pi

[bones] 23/9/2019 09:31

This would be a good time for the directors to step in for a few. They can buy below their recent option price and it might show some confidence in what they are doing.

[bones] 23/9/2019 09:02

One of the June 7th 1.7p buyers has bailed at 1.2p (371k of them). This is the technical problem we now have with so many stale bulls trapped in at that level and not being long term investors. The MM’s know this too.

It’s down to the company to make a breakthrough and announce a collaboration on bioprocessing, or some such deal.

[bones] 23/9/2019 08:41

Also the following, which the company needs to execute!:

”The total market for bioprocessing is in the region of $200Bn, at a growth rate of 10 percent per annum (Sartorius Results Presentation, H1 2019) driven by favourable demographics, increased healthcare spending, and advances in biosimilars and gene therapy. The Board believes there to be significant demand in this market for various analytical instruments used to analyse bioprocessing inputs and outputs at several stages in the process. The Board also believes that Microsaic's mass detection equipment could provide alternative tools for such analyses, with potential advantages such as ease of use, speed of testing, providing additional information and lower costs.”

”The MiD(R) ProteinID, was launched in January 2019. Just prior to launch, in December 2018, it was ranked in the most innovative products of 2018 by the Analytical Scientist Innovation Awards. The Board is optimistic about the prospects for further commercial adoption in the coming years.”

[bones] 23/9/2019 08:38

As the CEO stated:

"Bioprocessing remains a very exciting growth opportunity, and we continue to make good progress in developing products to meet specific bioprocessing applications, particularly in partnership with MIT and the Centre for Process Innovation ("CPI"), ahead of planned commercialisation. Microsaic has increased its industry profile and continues to garner interest in the use of its technology as a novel approach to the in-situ analysis of biologics during their manufacture."

[bones] 23/9/2019 08:32

Yes, we need a better stock market to get the potential valued here.

[dave4545] 23/9/2019 08:29

I'll never be not holding these bones. One biometrics Rns at 7am and they could double or more.

But that 1.7p bid from 1.4p was a mistake by the mm's, nobody is buying anything in this market so you need better numbers than what they put out, I was expecting way more turnover than that, would have sold more if I had a quote.

Anyway it's good to reduce all stocks atm, try and get your holdings down to more sensible amounts.

[bones] 23/9/2019 08:20

Are you on the way out then Dave or just gaming the prices?

[dave4545] 23/9/2019 08:10

It was my 150k at the open bones, surprised I got a quote tbh considering the hike up.

I thought it was quite a generous mark up on those numbers.

[bones] 23/9/2019 08:04

MM’s opening up with bid at 1.7p. Can expect plenty selling into that given the massive buying at that price in June since when the price has hardly ever been higher. Plenty looking to get their money back I reckon will act as a resistance level here.

[bones] 23/9/2019 07:48

Interims pretty much par for the course financially, ie little income and plenty of R&D and overheads. It’s all about the potential uses and markets of the products coming online and being distributed across the world.

Can the company secure orders for its new developments and can it break into bioprocessing? Note also the reference to longer term plans to get into point of care diagnostics.

How to value all of this? Hard to know!

[no1larafan] 20/9/2019 11:43

But now or you'll miss the train, all imo ?

[no1larafan] 20/9/2019 11:42

The buying spree has started!

[dave4545] 20/9/2019 11:01

200k buy on Nex just now at 1.55p so could get a little pre results rally.

[ny boy] 20/9/2019 10:53

Last trading day before results

[ny boy] 18/9/2019 20:52

Tick tock, towards next Monday’s results, happy holding for a few years but hoping to see some good progress to see us move 2p + this quarter.

[dave4545] 18/9/2019 12:36

If my only job in life was to be a market maker in msys I'd be happy.

Lots of days off and when there is action I'm well paid for it.

[dave4545] 18/9/2019 07:55

Not Miton style to sell a mere 250k well below the bid, if they still held and were selling they would either sell a huge block well below the price or work a load of stock.

This is the case of a pi with a online broker who quotes best price when others are not getting a quote to sell at 1.4p and decided to take the 1.275p instead of FOK the stock and getting a much better price.

[bones] 17/9/2019 12:47

I was not aware that Miton were in here? They are not listed in the 2017 (pre-placing) or 2018 financial statements as owning more than 3%. Whether they have less I cannot say but it would be a small investment if so.